User: Genecampaign Topic: IP
Category: patents :: everywhere
Last updated: Feb 12 2016 22:34 IST RSS 2.0
 
1 to 20 of 10,403    
CBI registers case against NIPER officials 12.2.2016 TOI: India
A case of alleged corruption has been registered by CBI against officials of National Institute of Pharmaceutical Education and Research (NIPER) and a private company in the purchase of licenses for accessing a global patent database software causing losses of Rs 10 ...
Also found in: [+]
Glaxo fined £37.6m for anti-competitive behaviour with Seroxat 12.2.2016 The Guardian -- Front Page

UK competition watchdog said pharmaceutical firm paid generic drugmakers £50m in return for them delaying cheaper versions of the blockbuster drug

GlaxoSmithKline has been fined £37.6m by Britain’s competition authority for anti-competitive behaviour in relation to its antidepressant Seroxat.

The Competition & Markets Authority said the pharmaceutical firm had paid generic drugmakers more than £50m between 2001 and 2004 in return for them delaying the launch of cheaper versions of the blockbuster drug.

Continue reading...
Also found in: [+]
Patient challenges patent on two key HIV drugs 11.2.2016 TOI: Cities
patient suffering with HIV has opposed patent applications for two important HIV medicines, dolutegravir and cabotegravir, thwarting an attempt by ViiV Healthcare (a joint venture by Pfizer and GlaxoSmithKline) to obtain monopoly rights on the drugs, in ...
Also found in: [+]
India offers better opportunity for biosimilar drugs: Cadila Healthcare founder Pankaj Patel 11.2.2016 ET: Pharma
Biosimilars are follow-on versions of biologic drugs and far more complex and more difficult to copy than generic drugs because of the structure of the molecule.
Also found in: [+]
In five years, US FDA rejected 13,334 Indian products 9.2.2016 ET: Pharma
In January 2016, India saw 228 rejections, China saw 314, pointing to another year rejections at a time when the Centre has been advancing the 'Make-in-India campaign.
Also found in: [+]
In 5 years, US FDA rejected 13,000 Indian products 9.2.2016 TOI: India
As many as 13,334 products made in India were rejected by the US Food and Drug Administration (FDA) between 2010 and 2015, FDA data shows. During the period, it rejected imports of 15,087 Chinese ...
Also found in: [+]
US pharma body slams Indian patent regime 9.2.2016 TOI: India Business
Criticizing India’s “weak” intellectual property rights (IPR) regime, PhRMA (Pharmaceutical Research and Manufacturers of America), which represents leading pharma and biotech companies in the US, has suggested India remain on the Priority Watch List in the 2016 Special 301 Report.
Also found in: [+]
Seminar discusses Biological Diversity Act and its flaws 7.2.2016 TOI: Cities
Cell for awareness and research in environmental law studies (CARES), National Law Institute University, Bhopal, in collaboration with Madhya Pradesh state biodiversity board organized BIOSANCTUM 2016-a national seminar on Biological Diversity Act, 2002 and ABS Regulations, 2014 on ...
Also found in: [+]
The pill that costs $9,000 in US sells for $70 in India 7.2.2016 ET: Pharma
Typically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the US.
Also found in: [+]
Nirmala Sitharaman asks pharmaceutical industry to reduce dependence on API imports 5.2.2016 DNA: Recent Columns
Commerce and Industry Minister Nirmala Sitharaman on Friday raised serious concerns over increasing imports of Active Pharmaceutical Ingredients (APIs) and asked the experts and industry to work in the direction to reduce the dependence on imports. "When we are setting up pharmaceutical and biotechnology hubs... the dependence on imported APIs worries me a lot," she said at the Global Biotechnology Summit. Sitharaman said as India is a global hub of generic medicines and biotechnology centres, industry, academia and experts should work in reducing the increasing imports. India is hugely dependent on China for import of the APIs, which are the raw materials for medicines. Indian firms imported APIs and intermediates worth nearly $3 billion (nearly Rs 20,343 crore) in 2010-11 with China alone accounting for $1.88 billion (nearly Rs 12,748.28 crore).  The minister said both developing and developed countries are dependent on India for affordable generic medicines. Further, the Commerce Ministry is ...
Also found in: [+]
Dependence on imported APIs is worrisome: Nirmala Sitharaman 5.2.2016 ET: Foreign Trade
Commerce and industry Minister Nirmala Sitharaman today raised serious concerns over increasing imports of active pharmaceutical ingredients.
Also found in: [+]
China seeks food security with $43 billion bid for Syngenta 3.2.2016 TOI: Intl Business
China made its boldest overseas takeover move when state-owned ChemChina agreed a $43 billion bid for Swiss seeds and pesticides group Syngenta on Wednesday, aiming to improve domestic food production. This also marks a setback for US firm Monsanto, which failed to buy Syngenta last year.
Also found in: [+]
Union Minister of Science & Technology and Earth Sciences Dr. HARSH Vardhan appeals to the scientific community to synergize professionally 3.2.2016 Govt of india: PIB
Union Minister of Science & Technology and Earth Sciences Dr. HARSH Vardhan appeals to the scientific community to synergize professionally

Also found in: [+]
Indian firm developing vaccine for Zika virus 3.2.2016 The Assam Tribune
Indian firm developing vaccine for Zika virus
Also found in: [+]
Indian company claims breakthrough in developing vaccine to fight Zika 3.2.2016 TOI: India
"We believe we have an early mover advantage in developing the Zikavac and we are probably the first in the world to file for global patent for Zika vaccine candidates," said Krishna Ella, CMD Bharat ...
Also found in: [+]
India may lead the race to bring out vaccine for Zika virus: Report 3.2.2016 DNA: Money
Amid the scare over the mosquito-borne Zika virus, which has now been declared an international public health emergency by the World Health Organization (WHO), scientists in India have claimed that they have developed the world's first vaccine for it. According to NDTV, scientists at a Hyderabad lab said they have developed not one, but two vaccines, using a live Zika virus imported officially. The virus, linked to severe birth defects in thousands of babies in Brazil, is spreading rapidly in the Americas, and WHO officials have expressed concern that it could hit Africa and Asia as well. "On Zika, we are probably the first vaccine company in the world to file a vaccine candidate patent about nine months ago," Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech Ltd told NDTV.  Dr. Soumya Swaminathan, Director General of Indian Council of Medical Research (ICMR ) said that they would see the feasibility of taking it forward and that the vaccine could be a a good example of a 'Make in India' ...
Also found in: [+]
Bharat Biotech gets breakthrough in developing Zika vaccine 3.2.2016 ET: Pharma
harat Biotech claimed to have achieved a breakthrough in developing a vaccine to fight Zika virus which causes serious birth defects in children.
Also found in: [+]
Dr. Harsh Vardhan inaugurates the “MAGIC” process lab at CSIR-National Chemical Laboratory, Pune 3.2.2016 Govt of india: PIB
The Union Minister for Science & Technology & Earth Sciences, Dr Harsh Vardhan, inaugurated a unique MAGIC [Modular, Agile, Intensified & Continuous] Process Lab at CSIR-National Chemical Laboratory (CSIR-NCL) Pune last evening. While inaugurating the facility he announced that “The MAGIC processes and plants will bring about a paradigm shift in the way in which India’s Fine and Specialty Chemicals industry will operate in the future.
Also found in: [+]
Power, water supplies to Cong MP's bungalow cut 3.2.2016 TOI: India
Power and water supply connections were snapped to the bungalow occupied by Congress MP Adhir Ranjan Chowdhury on Tuesday as officials from the urban development ministry started the physical eviction ...
Also found in: [+]
RBI to create enabling framework for growth of startups 2.2.2016 ET: Policy
A liberalised patent regime is being brought to help start-up businesses register patents, for which the fee will be slashed by 80 per cent.
Also found in: [+]
1 to 20 of 10,403